These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2458874)

  • 21. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
    Okada Y
    Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence in advanced cancer of an activated leukocyte state to explain the reversible defect in transmembrane signaling and leukocyte adherence inhibition to extracts of cancer.
    Shenouda G; Thomson DM
    Clin Immunol Immunopathol; 1984 Aug; 32(2):212-23. PubMed ID: 6375921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific immunodiagnosis of hepatoma by tube leukocyte adherence inhibition assay and a modified method of repeated tube leukocyte adherence inhibition assay.
    Morizane T; Kumagai N; Tsuchimoto K; Watanabe T; Tsuchiya M
    Cancer Res; 1980 Aug; 40(8 Pt 1):2928-34. PubMed ID: 6248217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of the leukocyte adherence inhibition (LAI), CA 19-9, and tissue polypeptide antigen (TPA) tests in the diagnosis of pancreatic cancer.
    Meduri F; Doni MG; Merenda R; Bizzarini M; Neri D; Gerunda GE; Maffei Faccioli A
    Cancer; 1989 Sep; 64(5):1103-6. PubMed ID: 2667748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunologic characteristics of the leukocyte adherence inhibition assay in rheumatoid arthritis.
    Tannenbaum H; Wild J
    Clin Invest Med; 1983; 6(3):153-9. PubMed ID: 6360455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Requirement for autologous cancer extracts and lipoxygenation of arachidonic acid for human T-cell responses in leukocyte adherence inhibition and transmembrane potential change assays.
    Shenouda G; Thomson DM; MacFarlane JK
    Cancer Res; 1984 Mar; 44(3):1238-45. PubMed ID: 6420056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Demonstration of tube leukocyte adherence inhibition assay with coded samples of blood.
    Thomson DM
    Cancer Res; 1979 Feb; 39(2 Pt 2):627-9. PubMed ID: 83917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Leukocyte adherence inhibition test in tumor patients].
    Martínez Martínez B; Ordóñez Gallego A; Juárez Alonso S; González Barón M; Montero García JM
    Rev Esp Oncol; 1982; 29(4):735-42. PubMed ID: 6927371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effector lymphocyte response to homologous tumor antigens in various stages of malignant disease as monitored by leukocyte adherence inhibition--cell mediated immunity (LAI-CMI).
    Tsang PH; Roboz JP; Holland JF; Bekesi JG
    Immunol Lett; 1988 Jan; 17(1):63-70. PubMed ID: 3280478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Modification of leucocyte adherence inhibition (LAI) assay with 51Cr-labelled leucocytes (author's transl)].
    Varga A; Stosiek P; Kasper M
    Allerg Immunol (Leipz); 1980; 26(2):171-8. PubMed ID: 6449844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specificity of tumor antigen recognition by T-lymphocytes in the leukocyte adherence inhibition (LAI) assay in patients with breast cancer.
    Tsang PH; Holland JF; Bekesi JG
    J Clin Lab Immunol; 1982 Dec; 9(3):151-7. PubMed ID: 6762442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversible abnormal nonadherence to glass and responsiveness to chemoattractants of leukocytes from patients with advanced cancer.
    Thomson DM
    J Natl Cancer Inst; 1984 Sep; 73(3):607-16. PubMed ID: 6088879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extraction of human organ-specific cancer neoantigens from cancer cells and plasma membranes with 1-butanol.
    Labateya N; Thomson DM; Durko M; Shenouda G; Robb L; Scanzano R
    Cancer Res; 1987 Feb; 47(4):1058-64. PubMed ID: 3100029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 1. Detection of cellular sensitization of peripheral blood lymphocytes using the LAI test].
    Ludwig HJ; Storch H
    Zentralbl Gynakol; 1986; 108(10):593-606. PubMed ID: 3526755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune reactivity to Thomsen-Friedenreich antigen in patients with lung cancer detected by superoxide assay-leukocyte adherence inhibition test.
    Ichinose Y; Yagawa K; Kaku M; Hara N; Ohta M
    Cancer Res; 1985 Sep; 45(9):4473-7. PubMed ID: 2992780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a Mr 40,000 polypeptide from colorectal cancer which expresses organ-specific cancer neoantigen activity as determined by leukocyte adherence inhibition.
    Artigas C; Thomson DM; Durko M; Sutherland M; Scanzano R; Shenouda G; Dubois AE
    Cancer Res; 1986 Apr; 46(4 Pt 1):1874-81. PubMed ID: 2418955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The leukocyte adherence inhibition assay in rheumatoid arthritis.
    Tannenbaum H
    J Rheumatol; 1979; 6(6):645-55. PubMed ID: 393822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recognition of a purified Mr-40,000 organ-specific immunogen of human lung cancer by class II-restricted T-cells.
    Thomson DM; Sutherland M; Scanzano R; Shenouda G
    J Natl Cancer Inst; 1987 Oct; 79(4):653-61. PubMed ID: 2443737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radioisotopic 51Cr-leukocyte adherence inhibition (LAI) assay. I. Demonstration of anti-tumor immunity in patients with breast carcinoma.
    Tsang PH; Tangnavarad K; Lesnick G; Perloff M; Holland JF; Bekesi JG
    J Immunol Methods; 1980; 36(2):119-35. PubMed ID: 7000908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A leukocyte adherence inhibition (LAI) assay of anti-tumor immunity in rats using selective radioimmunological assessment of adherence of T lymphocytes and monocytes.
    Morizane T; Sjögren HO
    Int J Cancer; 1983 Jun; 31(6):803-12. PubMed ID: 6345408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.